KIMI IGUCHI - 22 Nov 2021 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role: CFO & Treasurer
Signature: /s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Kimi Iguchi
Issuer symbol: SAGE
Transactions as of: 22 Nov 2021
Net transactions value: +$4,760
Form type: 4
Filing time: 23 Nov 2021, 16:15:56 UTC
Previous filing: 21 Oct 2021
Next filing: 15 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SAGE	Common Stock	Options Exercise	$3,400	+2,500	+5.3%	$1.36	50,100	22 Nov 2021	Direct
transaction	SAGE	Common Stock	Options Exercise	$1,360	+1,000	+2%	$1.36	51,100	23 Nov 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SAGE	Stock Option (Right to Buy)	Options Exercise	$0	-2,500	-83%	$0.000000	495	22 Nov 2021	Common Stock	2,500	$1.36	Direct	F1
transaction	SAGE	Stock Option (Right to Buy)	Options Exercise	$0	-495	-100%	$0.000000^*	0	23 Nov 2021	Common Stock	495	$1.36	Direct	F1
transaction	SAGE	Stock Option (Right to Buy)	Options Exercise	$0	-505	-3.6%	$0.000000	13,542	23 Nov 2021	Common Stock	505	$1.36	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on March 12, 2016.
F2	The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on July 23, 2016.